IM Cannabis Announces the Appointment of Mr. Alon Dayan to its Board of Directors

Core Insights - IM Cannabis Corp. has appointed Mr. Alon Dayan to its board of directors effective December 31, 2025, enhancing its leadership team with expertise in technology and business development [1][2]. Company Overview - IM Cannabis Corp. is an international medical cannabis company that provides premium cannabis products to medical patients in Israel and Germany, focusing on sustainable and profitable growth in these high-value markets [3]. - The company operates a transnational ecosystem powered by a data-driven approach and a globally sourced product supply chain, aiming to amplify its commercial and brand power in the global cannabis market [3]. Operations - In Israel, IM Cannabis operates through subsidiaries that import and distribute cannabis to medical patients, utilizing proprietary data and patient insights [4]. - The company also runs medical cannabis retail pharmacies and online platforms in Israel to ensure safe delivery and quality control of its products throughout the value chain [4]. - In Germany, IM Cannabis operates through Adjupharm GmbH, distributing cannabis to pharmacies for medical cannabis patients [4].